123 related articles for article (PubMed ID: 220644)
1. Possible participation of glucocorticoid in elevation of 3',5'-cyclic AMP levels through inhibition of cyclic AMP phosphodiesterase.
Tanigawa Y; Kitamura A; Kawamura M; Shimoyama M; Fujii K; Kohri Y; Ueda I
Physiol Chem Phys; 1978; 10(5):443-8. PubMed ID: 220644
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y
Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431
[TBL] [Abstract][Full Text] [Related]
3. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
4. Studies on the effect of nicotinamide and ethylnicotinic acid on cyclic AMP phosphodiesterase from rat liver.
Hoshi Y
Bull Osaka Med Sch; 1975 Oct; 21(2):77-91. PubMed ID: 181108
[No Abstract] [Full Text] [Related]
5. Griseolic acid, an inhibitor of cyclic adenosine 3',5'-monophosphate phosphodiesterase. I. Taxonomy, isolation and characterization.
Nakagawa F; Okazaki T; Naito A; Iijima Y; Yamazaki M
J Antibiot (Tokyo); 1985 Jul; 38(7):824-9. PubMed ID: 2993218
[TBL] [Abstract][Full Text] [Related]
6. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclic nucleotide phosphodiesterase activity by an endogenous factor.
Ho RJ; Russell TR; Asakawa T; Hucks MW
J Cyclic Nucleotide Res; 1975; 1(2):81-8. PubMed ID: 177458
[TBL] [Abstract][Full Text] [Related]
8. Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3':5'-monophosphate and potentiation of adenylate cyclase-activating agents.
Marone G; Lichtenstein LM; Plaut M
J Pharmacol Exp Ther; 1980 Nov; 215(2):469-78. PubMed ID: 6255128
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.
Silver PJ; Lepore RE; O'Connor B; Lemp BM; Hamel LT; Bentley RG; Harris AL
J Pharmacol Exp Ther; 1988 Oct; 247(1):34-42. PubMed ID: 2845058
[TBL] [Abstract][Full Text] [Related]
10. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
Miot F; Erneux C; Wells JN; Dumont JE
Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity.
Nagata K; Ogawa T; Omosu M; Fujimoto K; Hayashi S
Arzneimittelforschung; 1985; 35(7):1034-6. PubMed ID: 2996562
[TBL] [Abstract][Full Text] [Related]
12. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
Whalin ME; Garrett RL; Thompson WJ; Strada SJ
Second Messengers Phosphoproteins; 1988-1989; 12(5-6):311-25. PubMed ID: 2856115
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone inhibits purified taste bud membrane adenosine 3',5'-monophosphate phosphodiesterase activity.
Law JS; Henkin RI
Res Commun Chem Pathol Pharmacol; 1984 Mar; 43(3):449-62. PubMed ID: 6326212
[TBL] [Abstract][Full Text] [Related]
14. Bovine taste bud cyclic adenosine 3', 5' monophosphate phosphodiesterase is inhibited by divalent metal ions.
Law JS; Henkin RI
Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):455-72. PubMed ID: 6314459
[TBL] [Abstract][Full Text] [Related]
15. Griseolic acid, a cAMP phosphodiesterase inhibitor, and its ester: increase in cellular cAMP levels and reduction of intraocular pressure.
Yamazaki M; Yasumoto T; Iijima Y; Yokoyama T; Fukami S; Kaneko M; Kiuchi Y; Mishima H
Adv Second Messenger Phosphoprotein Res; 1990; 24():502-6. PubMed ID: 1698412
[No Abstract] [Full Text] [Related]
16. Demonstration of functional compartments of cyclic AMP in rat platelets by the use of phosphodiesterase inhibitors.
Ashida S; Sakuma K
Adv Second Messenger Phosphoprotein Res; 1992; 25():229-39. PubMed ID: 1313259
[No Abstract] [Full Text] [Related]
17. Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase.
Bertram JS; Faletto MB
Cancer Res; 1985 May; 45(5):1946-52. PubMed ID: 2985240
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of psoralens on rat liver cyclic AMP phosphodiesterase.
Bovalini L; Lusini P; Simoni S; Vedaldi D; Andreassi L; Dall'Acqua F; Martelli P
Biochem Int; 1988 Jun; 16(6):991-8. PubMed ID: 2845992
[TBL] [Abstract][Full Text] [Related]
19. Effect of adrenaline and glucocorticoids on monocyte cAMP-specific phosphodiesterase (PDE4) in a monocytic cell line.
Delgado M; Fernández-Alfonso MS; Fuentes A
Arch Dermatol Res; 2002 Jul; 294(4):190-7. PubMed ID: 12111350
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of meiotic arrest in mouse oocytes by purines: modulation of cAMP levels and cAMP phosphodiesterase activity.
Downs SM; Daniel SA; Bornslaeger EA; Hoppe PC; Eppig JJ
Gamete Res; 1989 Jul; 23(3):323-34. PubMed ID: 2476369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
